ARTICLE | Company News
Albany Molecular Research other research news
September 4, 2001 7:00 AM UTC
AMRI received a $98,000 Phase I SBIR grant from the National Institute of Drug Abuse to use its biocatalysis technology to improve the pharmacological profile of the institute's lead compounds for coc...